A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients

Obesity Surgery

Volumn 20, Issue 6, 2010, Pages 685-691

  Ulitsky, Alex ^a   Ananthakrishnan, Ashwin N ^a   Komorowski, Richard ^a   Wallace, James ^a   Surapaneni, Sri Naveen ^a   Franco, Jose ^a   Saeian, Kia ^a   Gawrieh, Samer ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Hepatosteatosis; Liver biopsy; Morbid obesity; NAFLD; NASH; Predictive model

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONYLUREA DERIVATIVE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BARIATRIC SURGERY; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SLEEP APNEA SYNDROME;

ADULT; BIOPSY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OBESITY, MORBID; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK FACTORS;

EID: 77953232280     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0118-y     Document Type: Article

References (28)

1. M Charlton 2004 Nonalcoholic fatty liver disease: a review of current understanding and future impact Clin Gastroenterol Hepatol 2 12 1048 1058 10.1016/S1542-3565(04)00440-9 15625647 (Pubitemid 40037633)
2. M Lazo JM Clark 2008 The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 4 339 350 10.1055/s-0028- 1091978 18956290
3. CA Matteoni ZM Younossi T Gramlich, et al. 1999 Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 6 1413 1419 10.1016/S0016-5085(99)70506-8 1:STN:280:DyaK1M3nvVamtw%3D%3D 10348825 (Pubitemid 29258890)
4. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 346 16 1221 1231 10.1056/NEJMra011775 1:CAS:528:DC%2BD38XivVOmsrY%3D 11961152 (Pubitemid 34984585)
5. E Bugianesi N Leone E Vanni, et al. 2002 Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 1 134 140 10.1053/gast.2002.34168 12105842 (Pubitemid 34747534)
6. AA Bravo SG Sheth S Chopra 2001 Liver biopsy N Engl J Med 344 7 495 500 10.1056/NEJM200102153440706 1:STN:280:DC%2BD3M7ksVehtw%3D%3D 11172192 (Pubitemid 32164902)
7. G Marchesini E Bugianesi G Forlani, et al. 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 4 917 923 10.1053/jhep.2003.50161 12668987 (Pubitemid 36397405)
8. JB Dixon PS Bhathal PE O'Brien 2001 Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 1 91 100 10.1053/gast.2001.25540 1:CAS:528: DC%2BD3MXlt1ykt70%3D 11438497
9. JP Ong H Elariny R Collantes, et al. 2005 Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients Obes Surg 15 3 310 315 10.1381/0960892053576820 15826462 (Pubitemid 40463594)
10. L Spaulding T Trainer D Janiec 2003 Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass Obes Surg 13 3 347 349 10.1381/096089203765887633 12841891 (Pubitemid 36718450)
11. DE Kleiner EM Brunt M Van Natta, et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 6 1313 1321 10.1002/hep.20701 15915461 (Pubitemid 40770284)
12. GM Campos K Bambha E Vittinghoff, et al. 2008 A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients Hepatology 47 6 1916 1923 10.1002/hep.22241 18433022 (Pubitemid 351945559)
13. F Harnois S Msika JM Sabate, et al. 2006 Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery Obes Surg 16 2 183 188 10.1381/096089206775565122 16469221
14. VW Wong GL Wong SW Tsang, et al. 2009 Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels Aliment Pharmacol Ther 29 4 387 396 10.1111/j.1365-2036. 2008.03896.x 1:CAS:528:DC%2BD1MXivVGrsb4%3D 19035982
15. AL Fracanzani L Valenti E Bugianesi, et al. 2008 Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 3 792 798 10.1002/hep.22429 1:CAS:528:DC%2BD1cXhtFKrsLbK 18752331
16. D Sorbi J Boynton KD Lindor 1999 The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease Am J Gastroenterol 94 4 1018 1022 10.1111/j.1572-0241.1999.01006.x 1:CAS:528:DyaK1MXisVOltLc%3D 10201476
17. P Angulo JC Keach KP Batts, et al. 1999 Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 6 1356 1362 10.1002/hep.510300604 1:STN:280:DC%2BD3c%2Fkt1ejtQ%3D%3D 10573511
18. N Hossain A Afendy M Stepanova, et al. 2009 Independent predictors of fibrosis in patients with non-alcoholic fatty liver disease Clin Gastroenterol Hepatol 7 1224 1229 10.1016/j.cgh.2009.06.007 1:CAS:528:DC%2BC3cXlsFOisA%3D%3D 19559819
19. DN Amarapurka AD Amarapurkar ND Patel, et al. 2006 Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis Ann Hepatol 5 1 30 33 1:STN:280:DC%2BD287ktFGktA%3D%3D 16531962
20. PM Gholam L Flancbaum JT Machan, et al. 2007 Nonalcoholic fatty liver disease in severely obese subjects Am J Gastroenterol 102 2 399 408 10.1111/j.1572-0241.2006.01041.x 1:CAS:528:DC%2BD2sXivF2ksb0%3D 17311652 (Pubitemid 46160554)
21. GA Abrams SS Kunde AJ Lazenby, et al. 2004 Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease Hepatology 40 2 475 483 10.1002/hep.20323 15368453 (Pubitemid 39062866)
22. ER Kallwitz G Guzman V TenCate, et al. 2009 The histologic spectrum of liver disease in African-American, non-Hispanic White, and Hispanic obesity surgery patients Am J Gastroenterol 104 1 64 69 10.1038/ajg.2008.12 19098851
23. P Sorrentino G Tarantino P Conca, et al. 2004 Silent non-alcoholic fatty liver disease-a clinical-histological study J Hepatol 41 5 751 757 10.1016/j.jhep.2004.07.010 1:CAS:528:DC%2BD2cXptFKku7Y%3D 15519647 (Pubitemid 39434304)
24. JM Clark 2006 The epidemiology of nonalcoholic fatty liver disease in adults J Clin Gastroenterol 40 Suppl 1 S5 10 16540768
25. ZM Younossi T Gramlich CA Matteoni, et al. 2004 Nonalcoholic fatty liver disease in patients with type 2 diabetes Clin Gastroenterol Hepatol 2 3 262 265 10.1016/S1542-3565(04)00014-X 15017611 (Pubitemid 38293314)
26. EM Brunt DE Kleiner LA Wilson, et al. 2009 Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network Hepatology 49 3 809 820 10.1002/hep.22724 19142989
27. I Friis-Liby F Aldenborg P Jerlstad, et al. 2004 High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease Scand J Gastroenterol 39 9 864 869 10.1080/00365520410006431 1:CAS:528: DC%2BD2cXnvV2qtL4%3D 15513385 (Pubitemid 39215458)
28. KC Sung MC Ryan AM Wilson 2009 The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects Atherosclerosis 203 2 581 586 10.1016/j. atherosclerosis.2008.07.024 1:CAS:528:DC%2BD1MXjslyiurs%3D 18774133